CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
75.63
-1.12 (-1.46%)
At close: Dec 5, 2025, 4:00 PM EST
75.65
+0.02 (0.03%)
After-hours: Dec 5, 2025, 7:45 PM EST
CVS Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for CVS Health stock have an average target of 87.72, with a low estimate of 70 and a high estimate of 102. The average target predicts an increase of 15.99% from the current stock price of 75.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 6 | 7 | 6 |
| Buy | 8 | 11 | 11 | 11 | 11 | 11 |
| Hold | 3 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 17 | 18 | 19 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Hold Maintains $77 → $86 | Hold | Maintains | $77 → $86 | +13.71% | Dec 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $103 → $102 | Buy | Maintains | $103 → $102 | +34.87% | Nov 13, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $99 → $100 | Strong Buy | Maintains | $99 → $100 | +32.22% | Nov 3, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $85 → $95 | Buy | Maintains | $85 → $95 | +25.61% | Oct 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $81 → $93 | Buy | Maintains | $81 → $93 | +22.97% | Oct 30, 2025 |
Financial Forecast
Revenue This Year
402.82B
from 370.66B
Increased by 8.68%
Revenue Next Year
423.18B
from 402.82B
Increased by 5.05%
EPS This Year
6.67
from 3.66
Increased by 82.11%
EPS Next Year
7.22
from 6.67
Increased by 8.31%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 422.6B | 459.5B | ||||
| Avg | 402.8B | 423.2B | ||||
| Low | 389.6B | 393.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 14.0% | 14.1% | ||||
| Avg | 8.7% | 5.1% | ||||
| Low | 5.1% | -2.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.04 | 7.88 | ||||
| Avg | 6.67 | 7.22 | ||||
| Low | 6.10 | 6.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 92.2% | 18.2% | ||||
| Avg | 82.1% | 8.3% | ||||
| Low | 66.5% | -2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.